References in periodicals archive ?
PS can help to fold ON and increase the transfection efficiency in the liposome-mediated gene transfer system.
We are pleased to be working with DNT, a leader in nanotechnology, to develop unique and highly efficient transfection reagents that will be marketed through the Novagen brand of products," stated Lisa Johnson, Vice President of Corporate Development for EMD Biosciences.
In 1989, the transfection of the sea urchin spermatozoa was demonstrated by Arezzo (1989) and the same year an interesting paper showed the production of transgenic mice after employing transfected spermatozoa (Lavitrano et al.
To establish the concentration of PEI necessary for optimal transfection, small goldfish (3-10 g) were injected with 1 g CMV-LUC in 4 [micro]L complexed with 0, 3, 6, and 9 eq of PEI in a 5% glucose solution.
Drawing on its cell therapy expertise, MaxCyte designed a portfolio of products including the MaxCyte STX[R] Scalable Transfection System and MaxCyte VLX[R] Large Scale Transfection System, ideal tools for use in drug discovery research and screening and protein production environments.
The global transfection technologies market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
5 November 2014 - US diagnostics and lab products maker Thermo Fisher Scientific (NYSE:TMO) announced Tuesday the launch of Lipofectamine MessengerMAX, a new high-efficiency transfection reagent for mRNA delivery in neurons and primary cell types.
Twenty eight hours after transfection, [micro]ci/well [(3)H]-thymidine (Amersham Biosciences, Buckinghamshire, UK) was added to the media of siRNA-or mock control-transfected cells, untransfected cells (as positive control) and staurosporine-treated (5 [micro]M) (Sigma, St.
Gene therapy company uniQure NV (NasdaqGS:QURE) revealed on Tuesday the successful transfection of liver cells with the porphobilinogen deaminase gene (PBGD) from an ongoing Acute Intermittent Porphyria (AIP) dose-escalation Phase I trial of of AMT-021 conducted in partnership with the AIPGENE Consortium, a pan-European collaboration.
Induced pluripotent stem cell (iPSC)-derived cell models, such as Cellular Dynamics International's iCell Cardiomyocytes, show robust transfection with ViaFect Transfection Reagent, enabling assays not possible with other reagents.
5]/ml into 96-well plates, and then divided into blank control group, blank transfection group, stealth_115 group, stealth_144 group and stealth_268 group.